Determinants of cost of routine immunization programme in India

被引:9
|
作者
Chatterjee, Susmita [1 ]
Ghosh, Arpita [1 ]
Das, Palash [1 ]
Menzies, Nicolas A. [2 ,3 ]
Laxminarayan, Ramanan [4 ,5 ]
机构
[1] Publ Hlth Fdn India, Gurgaon, Haryana, India
[2] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA
[3] Harvard TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA USA
[4] Ctr Dis Dynam Econ & Policy, Washington, DC USA
[5] Princeton Univ, Princeton Environm Inst, Princeton, NJ 08544 USA
基金
比尔及梅琳达.盖茨基金会;
关键词
Cost; Determinant; Routine immunization; India; MOLDOVA;
D O I
10.1016/j.vaccine.2018.05.006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The costs of delivering routine immunization services in India vary widely across facilities, districts and states. Understanding the factors influencing this cost variation could help predict future immunization costs and suggest approaches for improving the efficiency of service provision. We examined determinants of facility cost for immunization services based on a nationally representative sample of sub-centres and primary health centres (99 and 89 facilities, respectively) by regressing logged total facility costs, both including and excluding vaccine cost, against several explanatory variables. We used a multi-level regression model to account for the multi-stage sampling design, including state- and district-level random effects. We found that facility costs were significantly associated with total doses administered, type of facility, salary of the main vaccinator, number of immunization sessions, and the distance of the facility from the nearest cold chain point. Use of pentavalent vaccine by the state was an important determinant of total facility cost including vaccine cost. India is introducing several new vaccines including some supported by Gavi. Therefore, the government will have to ensure that additional resources will be made available after the support from Gavi ceases. (C) 2018 The Authors. Published by Elsevier Ltd.
引用
收藏
页码:3836 / 3841
页数:6
相关论文
共 50 条
  • [41] Cost-effectiveness analysis of routine immunization and supplementary immunization activity for measles in a health district of Benin
    Kaucley, Landry
    Levy, Pierre
    [J]. COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2015, 13
  • [42] BENEFICIARY ATTRACTIVENESS AND COST AS DETERMINANTS OF RESPONSES TO ROUTINE REQUESTS FOR HELP
    GROSS, AE
    WALLSTON, BS
    PILIAVIN, IM
    [J]. SOCIOMETRY, 1975, 38 (01): : 131 - 140
  • [43] Committee for Immunization Programme and registry and changes in the National Immunization Programme in Spain
    Limia Sanchez, Aurora
    Olmedo Luceron, Carmen
    Soler Soneira, Marta
    Cantero Gudino, Elena
    Sanchez-Cambronero Cejudo, Laura
    [J]. REVISTA ESPANOLA DE SALUD PUBLICA, 2020, 94
  • [44] New combination vaccines: backdoor entry into India's universal immunization programme?
    Madhavi, Y.
    [J]. CURRENT SCIENCE, 2006, 90 (11): : 1465 - 1469
  • [45] Current costs & projected financial needs of India's Universal Immunization Programme
    Chatterjee, Susmita
    Pant, Manish
    Haldar, Pradeep
    Aggarwal, Mahesh Kumar
    Laxminarayan, Ramanan
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 2016, 143 : 801 - 808
  • [46] COST OF ROUTINE IMMUNIZATION IN CHILDREN UNDER ONE YEAR IN THE YEAR 2016 IN ECUADOR
    Jimbo, R.
    Sanchez, X.
    Henriquez-Trujillo, A. R.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A929 - A929
  • [47] Rotavirus disease burden and potential cost benefit of routine immunization in a large HMO
    Zangwill, KM
    Wickham, C
    Marcy, SM
    Lee, H
    Partridge, S
    Vadheim, C
    Chang, SJ
    Jain, V
    Glass, R
    Ward, JI
    [J]. PEDIATRIC RESEARCH, 1999, 45 (04) : 178A - 178A
  • [48] The cost of not implementing routine neonates immunization programmes in HBsAg high prevalence countries
    Chauvin, P
    Ekra, D
    Plotkin, SA
    [J]. VACCINE, 2002, 20 (23-24) : 2848 - 2850
  • [49] IMMUNIZATION PROGRAMME FOR INFANTS
    VAHLQUIST, B
    [J]. ACTA PAEDIATRICA SCANDINAVICA, 1962, 51 (02): : 234 - &
  • [50] Rotavirus Disease Burden and Potential Cost Benefit of Routine Immunization in a Large HMO
    K M Zangwill
    C Wickham
    S M Marcy
    H Lee
    S Partridge
    C Vadheim
    S-J Chang
    V Jain
    R Glass
    J I Ward
    [J]. Pediatric Research, 1999, 45 : 178 - 178